Trial Outcomes & Findings for Priming Expectations and Motor Learning With tDCS (NCT NCT06039605)

NCT ID: NCT06039605

Last Updated: 2026-07-31

Results Overview

This will be calculated as the average of two trials of the motor task that are completed one week after the last training session. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

140 participants

Primary outcome timeframe

One-Week Follow-Up visit (Day 10)

Results posted on

2026-07-31

Participant Flow

Participant milestones

Participant milestones
Measure
Control
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
tDCS1
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Overall Study
STARTED
25
38
38
39
Overall Study
COMPLETED
25
38
38
39
Overall Study
NOT COMPLETED
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Priming Expectations and Motor Learning With tDCS

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Total
n=138 Participants
Total of all reporting groups
Age, Continuous
23.36 years
STANDARD_DEVIATION 11.34 • n=9 Participants
22.27 years
STANDARD_DEVIATION 3.73 • n=27 Participants
22.97 years
STANDARD_DEVIATION 7.40 • n=267 Participants
21.59 years
STANDARD_DEVIATION 3.38 • n=265 Participants
22.46 years
STANDARD_DEVIATION 6.65 • n=568 Participants
Sex: Female, Male
Female
13 Participants
n=9 Participants
15 Participants
n=27 Participants
17 Participants
n=267 Participants
19 Participants
n=265 Participants
64 Participants
n=568 Participants
Sex: Female, Male
Male
12 Participants
n=9 Participants
22 Participants
n=27 Participants
20 Participants
n=267 Participants
20 Participants
n=265 Participants
74 Participants
n=568 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=9 Participants
0 Participants
n=27 Participants
0 Participants
n=267 Participants
0 Participants
n=265 Participants
0 Participants
n=568 Participants
Race (NIH/OMB)
Asian
13 Participants
n=9 Participants
24 Participants
n=27 Participants
24 Participants
n=267 Participants
21 Participants
n=265 Participants
82 Participants
n=568 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=9 Participants
0 Participants
n=27 Participants
0 Participants
n=267 Participants
0 Participants
n=265 Participants
0 Participants
n=568 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=9 Participants
0 Participants
n=27 Participants
0 Participants
n=267 Participants
3 Participants
n=265 Participants
5 Participants
n=568 Participants
Race (NIH/OMB)
White
8 Participants
n=9 Participants
11 Participants
n=27 Participants
9 Participants
n=267 Participants
11 Participants
n=265 Participants
39 Participants
n=568 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=9 Participants
2 Participants
n=27 Participants
2 Participants
n=267 Participants
3 Participants
n=265 Participants
7 Participants
n=568 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=9 Participants
0 Participants
n=27 Participants
2 Participants
n=267 Participants
1 Participants
n=265 Participants
5 Participants
n=568 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=9 Participants
4 Participants
n=27 Participants
7 Participants
n=267 Participants
3 Participants
n=265 Participants
19 Participants
n=568 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
n=9 Participants
33 Participants
n=27 Participants
30 Participants
n=267 Participants
36 Participants
n=265 Participants
119 Participants
n=568 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
0 Participants
n=27 Participants
0 Participants
n=267 Participants
0 Participants
n=265 Participants
0 Participants
n=568 Participants
Region of Enrollment
United States
25 Participants
n=9 Participants
37 Participants
n=27 Participants
37 Participants
n=267 Participants
39 Participants
n=265 Participants
138 Participants
n=568 Participants

PRIMARY outcome

Timeframe: One-Week Follow-Up visit (Day 10)

Population: All subjects who were randomized, completed the study and had no missing Day 1 expectancy data.

This will be calculated as the average of two trials of the motor task that are completed one week after the last training session. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.

Outcome measures

Outcome measures
Measure
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Performance on Motor Task One Week After Final Training Session
48.02 time in seconds
Standard Deviation 5.61
47.14 time in seconds
Standard Deviation 6.86
47.23 time in seconds
Standard Deviation 7.09
48.50 time in seconds
Standard Deviation 7.02

SECONDARY outcome

Timeframe: Day 1, 2, and 3

Population: All subjects who were randomized, completed the study and had no missing Day 1 expectancy data.

This outcome measure will be measured as the slope of the line fitted to the motor task performance across all 30 training trials (this includes Day 1, 2 and 3), when trial is transformed to a logarithmic scale. This transformation is done to account for the fact that change in performance is non-linear. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.

Outcome measures

Outcome measures
Measure
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Change in Motor Performance Over the Course of Training
-0.09 Log(seconds) per trial
Standard Deviation 2.14
0.04 Log(seconds) per trial
Standard Deviation 2.01
-0.24 Log(seconds) per trial
Standard Deviation 2.46
0.45 Log(seconds) per trial
Standard Deviation 2.60

SECONDARY outcome

Timeframe: Day 1 and Follow-Up (Day 10)

Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing data for both Day 1 and Follow-Up expectancy data

This will be the change (Day 1 minus Day 10) in expectations of tDCS. The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral.

Outcome measures

Outcome measures
Measure
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Change in tDCS Expectations From Day 1 to Day 10
Change in tDCS Expectation
0.083 Score on a scale
Standard Deviation 1.54
-0.154 Score on a scale
Standard Deviation 1.40
0.108 Score on a scale
Standard Deviation 1.85
Change in tDCS Expectations From Day 1 to Day 10
Expectation at Baseline (Day 1)
4.50 Score on a scale
Standard Deviation 1.84
4.64 Score on a scale
Standard Deviation 1.56
5 Score on a scale
Standard Deviation 1.2
Change in tDCS Expectations From Day 1 to Day 10
Expectation at Follow-Up
4.41 Score on a scale
Standard Deviation 2.15
4.79 Score on a scale
Standard Deviation 1.79
4.89 Score on a scale
Standard Deviation 2.02

SECONDARY outcome

Timeframe: One-Week Follow-Up (Day 10)

Population: All subjects who were randomized completed the study and had no missing Day 1 expectancy or kinematics data.

This is the average amount of time spent in the home cup for each repetition, averaged across the two follow-up trials.

Outcome measures

Outcome measures
Measure
tDCS1
n=35 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
n=37 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=23 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Average Dwell Time
18.02 Time in seconds
Standard Deviation 4.85
17.90 Time in seconds
Standard Deviation 5.07
18.23 Time in seconds
Standard Deviation 5.04
18.39 Time in seconds
Standard Deviation 3.36

SECONDARY outcome

Timeframe: One-Week Follow-Up (Day 10)

Population: All subjects who were randomized completed the study and had no missing Day 1 expectancy or kinematics data.

his is the average peak velocity for the outward portion of each repetition, averaged across the two follow-up trials.

Outcome measures

Outcome measures
Measure
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=34 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
n=37 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=23 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Average Peak Reach Velocity
0.11 Velocity (m/s)
Standard Deviation 0.08
0.12 Velocity (m/s)
Standard Deviation 0.13
0.13 Velocity (m/s)
Standard Deviation 0.10
0.16 Velocity (m/s)
Standard Deviation 0.22

SECONDARY outcome

Timeframe: Days 1, 2, 3, and 10

Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing expectancy data

This is the coefficient of variation (CV) for tDCS expectation scores. It is calculated by dividing the standard deviation of the participant's expectations across study days (Days 1, 2, 3, and 10) by the mean expectation of these 4 study days. The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral.

Outcome measures

Outcome measures
Measure
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Variability in Transcranial Direct Current Stimulation Expectations
0.238 Ratio (for CV)
Standard Deviation 0.28
0.179 Ratio (for CV)
Standard Deviation 0.16
0.183 Ratio (for CV)
Standard Deviation 0.17

SECONDARY outcome

Timeframe: Days 1, 2, and 3

Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing Day 1 expectancy data

This is calculated using a 14-item self-rated questionnaire, with answers for each item ranging from 1 ("absent") to 10 ("severe"). A daily average score (ranging from 1 to 10) was calculated for each participant by averaging the 14 items. The reported values represent the mean of these daily averages per group. Higher values represent more severe symptoms (a worse outcome).

Outcome measures

Outcome measures
Measure
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 1
1.19 Score on a scale
Interval 1.0 to 3.0
1.24 Score on a scale
Interval 1.0 to 2.0
1.20 Score on a scale
Interval 1.0 to 2.0
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 2
1.13 Score on a scale
Interval 1.0 to 2.0
1.13 Score on a scale
Interval 1.0 to 2.0
1.15 Score on a scale
Interval 1.0 to 2.0
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 3
1.10 Score on a scale
Interval 1.0 to 2.0
1.10 Score on a scale
Interval 1.0 to 2.0
1.12 Score on a scale
Interval 1.0 to 2.0

SECONDARY outcome

Timeframe: Days 1, 2, 3, and 10

Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing expectancy data

The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral. This score was collected for each participant in the experimental group (tDCS1, tDCS2, tDCS3) across study days (Days 1, 2, 3, and 10).

Outcome measures

Outcome measures
Measure
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
tDCS Expectation Scores
Expectation Score at Baseline (Day 1)
4.50 Scale scores (for Days)
Standard Deviation 1.84
4.64 Scale scores (for Days)
Standard Deviation 1.56
5.00 Scale scores (for Days)
Standard Deviation 1.2
tDCS Expectation Scores
Expectation Score at Day 2
5.02 Scale scores (for Days)
Standard Deviation 1.84
5.13 Scale scores (for Days)
Standard Deviation 1.78
5.35 Scale scores (for Days)
Standard Deviation 1.7
tDCS Expectation Scores
Expectation Score at Day 3
5.02 Scale scores (for Days)
Standard Deviation 1.92
5.20 Scale scores (for Days)
Standard Deviation 1.85
5.35 Scale scores (for Days)
Standard Deviation 1.82
tDCS Expectation Scores
Expectation Score at Follow-Up (Day 10)
4.41 Scale scores (for Days)
Standard Deviation 2.15
4.79 Scale scores (for Days)
Standard Deviation 1.79
4.89 Scale scores (for Days)
Standard Deviation 2.02

Adverse Events

tDCS3

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

tDCS1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

tDCS2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Sydney Schaefer

Arizona State University

Phone: 480-727-6651

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place